Latest news
Recon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPSRAPS · Mon, 03 Aug 2026 16:51:00 GMTApnimed closes upsized IPO, raising $220.8 million - scanx.tradescanx.trade · Mon, 03 Aug 2026 07:00:00 GMTAPMD Stock News Today | Earnings, Events & Price Alerts - Intellectia AIIntellectia AI · Sun, 02 Aug 2026 17:51:11 GMTApnimed’s IPO Bags $192M for What Could Become the First Oral Sleep Apnea Drug - MedCity NewsMedCity News · Sun, 02 Aug 2026 07:00:00 GMTApnimed (NASDAQ:APMD) soars 56% as FDA decision could push sleep-apnea valuation close to $1 billion - TechStock²TechStock² · Fri, 31 Jul 2026 23:15:06 GMTUpdated: Apnimed raises $192M in IPO for potential 2027 sleep apnea drug launch - Endpoints NewsEndpoints News · Fri, 31 Jul 2026 07:00:00 GMTApnimed’s IPO dream comes true with upsized $192M IPO to fund sleep apnea pill launch - Fierce BiotechFierce Biotech · Fri, 31 Jul 2026 07:00:00 GMTCambridge biotech raises $192M in upsized IPO ahead of major FDA decision - The Business JournalsThe Business Journals · Fri, 31 Jul 2026 07:00:00 GMT